• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Mech Frazier, MA

Latest:

Geographic Variability of Medicaid Acceptance Among Allergists in the US

The proportion of allergists accepting Medicaid in the US varied significantly among and within states.


David Debono, MD

Latest:

Racial and Ethnic Disparities in Prior Authorizations for Patients With Cancer

The prior authorization process for patients with cancer demonstrates fewer days until submission and lower denial rates for Asian patients relative to White patients.


David Kerr, MBChB, DM

Latest:

Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 Diabetes

Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose monitoring.


Cheryl Lulias, MPA

Latest:

Improving Risk Stratification Using AI and Social Determinants of Health

Prediction models combining claims data with social determinants of health and additional, more-timely data sources using artificial intelligence (AI) can better identify individuals with the highest future medical spending.


Devika A. Shenoy, BS

Latest:

Interventions Addressing Cost-Related Medication Nonadherence in Diabetes: A Scoping Review

Many US patients with diabetes cannot afford their medical care. The authors review the impact of interventions that reduced and/or eliminated diabetes-related costs.


Michael Pangrace, BS

Latest:

Exploratory Study of Selected Stakeholder Insights Into Continuous Glucose Monitoring in T2D With Risk-Sharing Agreements

A small expert panel was selected to share professional experiences with risk-sharing agreements and advance the cost-effective utilization of continuous glucose monitoring–centered care in type 2 diabetes (T2D).


Paul G. Alexander, MD, MPH

Latest:

Population Health Strategies to Advance Health Equity: A Q&A With Dr Paul G. Alexander

Paul G. Alexander, MD, MPH, executive vice president and chief health equity and transformation officer, RWJBarnabas Health, speaks on strategies his organization implemented during the COVID-19 pandemic to address continuity of care and communication challenges in underserved communities and further efforts to improve health equity.


Rahaf Salah, PharmD

Latest:

Pharmaceutical Care Services for Patients With Diabetes: A Systematic Scoping Review

Major databases were systematically searched for articles reporting on pharmaceutical care services for patients with diabetes, and 86 pharmaceutical care services were qualitatively synthesized.


Rebecca Dent, MD, MSc

Latest:

The Growing ADC Landscape in TNBC Brings Questions, Opportunities: Rebecca Dent, MD, MSc

Rebecca Dent, MD, MSc, of the National Cancer Center in Singapore, gives insights on the use of antibody-drug conjugates (ADCs) in early breast cancer treatment.


Brady P. Horn, PhD

Latest:

An Assessment of Nurse Practitioner Low-Value Care Use in Primary Care

Primary care nurse practitioners were found to use low-value care at lower or relatively similar rates compared with the general clinician population.


Chen-Yang Hsu, MD

Latest:

Impact of COVID-19 Pandemic on Accessibility of Taiwanese Medical Care

The COVID-19 pandemic disrupted access to routine medical care in community populations in Taiwan. The unmet needs should be emphasized as normal life resumes.


Marla Black Morgan, MD | Image Credit: © Maggie L. Shaw
Marla Black Morgan, MD

Latest:

Addressing Myasthenia Gravis Diagnostic Delays and Access Barriers: Marla Black Morgan, MD

Marla Black Morgan, MD, looks to the future of research in both myasthenia gravis and rare neurological disorders by expanding data collection and identifying areas of potential difference in patient outcomes.


Tracey Iraca

Latest:

Patient Feedback for MDS: Insights and Closing Remarks

Medical experts offer their insights and closing remarks regarding patient feedback for MDS.


Kevin Varner, MS

Latest:

Advanced Care at Home at Scale in an Integrated Health Care System

Advanced care at home (otherwise known as hospital at home) can be scaled and provide care for a sizable portion of a hospital’s inpatient census, creating hospital capacity in an integrated delivery system.


Solomon J. Lubinga, PhD

Latest:

Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung Cancer

Compared with first-line immunotherapy or chemotherapy alone, combination chemoimmunotherapy for advanced/metastatic non–small cell lung cancer has significantly higher antineoplastic drug and associated medical costs.


Ayman Al-Hendy, MD, PhD

Latest:

Defining Value Among Treatment Options

Payer decision-makers discuss defining value among agents for unintended pregnancy, uterine fibroids, and endometriosis.


Marie Bosslett

Latest:

Mobile App Enables Accurate Remote Assessment of Atopic Dermatitis

Discover how the SkinTracker app enhances AD management through remote assessments, offering convenience and accuracy comparable to in-person visits.


Francis D. Pagani, MD, PhD

Latest:

Care Fragmentation Predicts 90-Day Durable Ventricular Assist Device Outcomes

This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.


Mark D. Williams, MD

Latest:

Emergency Department Risk Model: Timely Identification of Patients for Outpatient Care Coordination

The authors created a machine learning–based model to identify patients with major depressive disorder in the primary care setting at high risk of frequent emergency department visits, enabling prioritization for a care coordination program.


Abe Sutton, JD

Latest:

Identifying Chronic Kidney Disease Stage 3 With Excess Disease Burden

A high-risk cohort of beneficiaries with chronic kidney disease (CKD) stage 3 have a profile similar to patients with CKD stages 4 and 5, indicating potential benefit of earlier nephrology intervention.


Pooja Gokhale, PharmD

Latest:

Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual Care

Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine.


Lianne Granata, PharmD

Latest:

Collaboration to Transition Members to Preferred Formulary Dipeptidyl-Peptidase-4 Inhibitor

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.


Rishi Goyal, MD, PhD

Latest:

Community Health Workers’ Critical Role in Trust Building Between the Medical System and Communities of Color

The authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.


Joyce O’Shaughnessy, MD

Latest:

ASCO 2024 Review and Needed Future Research in CDK4/6 inhibitors Early Breast Cancer

A panel of experts review ASCO 2024 and the need for future research in CDK4/6 inhibitors.


Steven C. Hill, PhD

Latest:

Availability of Off-Marketplace Plans With Lower Premiums for Higher-Income Families

Off-marketplace plans are widely available, and individuals with higher incomes can obtain silver plans with low premiums off-marketplace.


Lindsey M. Roth, MPP

Latest:

Patient-Centered Oncology Care: Impact on Utilization, Patient Experiences, and Quality

Practices implementing a patient-centered oncology care pilot had improved quality, but utilization and patient experiences did not differ from comparison practices.


Harold J. Farber, MD, MSPH

Latest:

Evaluation of a Pediatric Asthma High-risk Scoring Algorithm

An asthma risk score using 7 clinically relevant parameters evaluated in a pediatric Medicaid managed care population can stratify risk for following-year asthma hospitalization.


Dr Luis Carvajal-Carmona | Image Credit: UC Davis Health
Luis Carvajal-Carmona, PhD

Latest:

Global Collaboration Is Key to Advancing Cancer Research: Luis Carvajal-Carmona, PhD

Luis Carvajal-Carmona, PhD, stresses the importance of global collaboration in cancer research to enhance understanding and treatment across diverse populations.


Jay S. Pickern, DBA

Latest:

Prior Authorizations and the Adverse Impact on Continuity of Care

Prior authorizations create substantial administrative and financial burdens on physicians and patients and can disrupt the continuity of care.


Amy Attaway, MD

Latest:

Diabetes Associated With Higher Health Care Utilization and Poor Outcomes After COPD-Related Hospitalizations

Patients with diabetes and chronic obstructive pulmonary disease (COPD) have worse outcomes when hospitalized and appear to be more vulnerable to respiratory and nonrespiratory complications after a COPD exacerbation, which highlights the need for targeted interventions in this population.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.